Focus on Cancer-logo

Focus on Cancer

ReachMD

ReachMD takes a closer look at the latest advances in cancer research, diagnosis, and treatment.

ReachMD takes a closer look at the latest advances in cancer research, diagnosis, and treatment.
More Information

Location:

United States

Networks:

ReachMD

Description:

ReachMD takes a closer look at the latest advances in cancer research, diagnosis, and treatment.

Language:

English


Episodes

Unraveling Disease Progression Predictors of mCRC

11/8/2018
More
Guest: Benjamin A. Weinberg, MD Dr. Benjamin Weinberg, assistant professor at Georgetown University, examines the determinants of disease progression of metastatic colorectal cancer and how these can lead to better approaches to tailored care and personalized management of your patients. Conversations on Colorectal Cancer is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Duration:00:01:59

NCCN Guidelines on mCRC in an Era of Tumor Sidedness

11/7/2018
More
Guest: Benjamin A. Weinberg, MD Keeping up with rapid advancements in mCRC, the NCCN updated their guidelines to encompass the perplexity of tumor sidedness. Dr. Benjamin Weinberg, Assistant Professor at Georgetown University, interprets the distinctions between right versus left-sided tumor sites and how these developments could impact your treatment selection for patients. Conversations on Colorectal Cancer is sponsored by Lilly. Content for this non-certified educational series is...

Duration:00:01:59

Expanding NCCN Guidelines for mCRC Care

11/7/2018
More
Guest: Benjamin A. Weinberg, MD The NCCN guidelines are the foundation of clinical practice, supporting the decisions of all in the oncology community. For this reason, advancements in the therapeutic landscape of metastatic colorectal cancer have led to necessary adaptations of the guidelines. Reflecting on these influential modifications is Dr. Benjamin Weinberg, Assistant Professor at Georgetown University. Conversations on Colorectal Cancer is sponsored by Lilly. Content for this...

Duration:00:03:29

Right-Left Divide: Prognostic Importance of Tumor Sidedness

11/7/2018
More
Guest: Benjamin A. Weinberg, MD Over the years, tumor sidedness has become an area of immense interest for the oncology community. And while they have shown inferior outcomes for patients with the primary site on the right side versus the left, questions still remain as to why. Dr. Benjamin Weinberg, an Assistant Professor at Georgetown University, details why sidedness may be a prominent prognostic indicator. Conversations on Colorectal Cancer is sponsored by Lilly. Content for this...

Duration:00:01:59

Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines

7/12/2018
More
Host: John J. Russell, MD Guest: Richard Wender, MD From oncologists to primary care, physicians are witnessing an alarming trend in younger patients: the rising risk of colorectal cancer. To investigate this growing threat, Dr. John Russell speaks with Dr. Rich Wender, Chief Cancer Control Officer at the American Cancer Society. Dr. Wender discusses the new colorectal cancer screening guidelines set forth and the methods behind the conclusion. While comparing past guidelines, Dr. Wender...

Duration:00:12:29

FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer

1/7/2018
More
Oncologists Dr. Sanjeeve Bala and Dr. Abhilasha Nair from FDA’s Oncology Center of Excellence discuss the recent approval of bevacizumab-awwb, a biosimilar to US-licensed Avastin, marketed as MVASI. MVASI is the first biosimilar approved in the US for the treatment of cancer. Released on December 21, 2017

Duration:00:08:29

Cervical Cancer Screening Updates: The Benefits of Co-Testing

1/1/2018
More
Host: Amy Mackey, MD Guest: Mark Spitzer, MD Prior to 2012 there were competing cervical cancer screening guidelines from the American Cancer Society and the United States Preventive Services Task Force (the USPSTF), leading providers to follow their own dictates when screening patients. In this edition of Advances in Women’s Health, host Dr. Amy Mackey is joined by Dr. Mark Spitzer with the Center for Colposcopy in New Hyde Park, Long Island, New York to discuss cervical cancer screening...

Duration:00:20:30

CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer

10/23/2017
More
Host: Shira Johnson, MD Guest: Robert Vonderheide, MD For years, the foundations of cancer treatment, surgery, chemotherapy, and radiation therapy were utilized with the objective of weakening cancer. But over the past several years, immunotherapy – therapies that enlist and strengthen the power of a patient’s immune system to attack tumors - has emerged as a new tool for fighting cancer. In August 2017, one such treatment approach, called Chimeric Antigen Receptor or CAR T-cell Therapy,...

Duration:00:11:00

CAR-T Therapy: A Breakthrough Tool for Fighting Cancer

10/23/2017
More
Host: Shira Johnson, MD Guest: Robert Vonderheide, MD For years, the foundations of cancer treatment, surgery, chemotherapy, and radiation therapy were utilized with the objective of weakening cancer. But over the past several years, immunotherapy – therapies that enlist and strengthen the power of a patient’s immune system to attack tumors - has emerged as a new tool for fighting cancer. In August 2017, one such treatment approach, called CAR-T (chimeric antigen receptor T-cell)...

Duration:00:11:00

Pancreatic Cancer: The Hunt to Catch a Silent Killer

8/12/2017
More
Host: John J. Russell, MD Guest: Harish Lavu, MD Pancreatic cancer is projected to become the second leading cause of cancer-related death in the United States by 2020. This is due, in large part, to its insidious onset and subtle presentation even at late stages, many symptoms of which are often attributed to common and less serious conditions in aging populations. Dr. Harish Lavu, Head of Hepatopancreatobiliary Surgery at Jefferson University, talks with host Dr. John Russell about the...

Duration:00:16:30

FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer

7/28/2017
More
FDA medical oncologists discuss the approval of osimertinib for EGFR mutation-positive non-small cell lung cancer. Released July 28, 2017

Duration:00:05:59

FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer

7/25/2017
More
FDA medical oncologists discuss the FDA approvals of brigatinib and ceritinib for ALK-positive non-small cell lung cancer. Released July 25, 2017

Duration:00:08:59

The CAM Guide to Cancer: An Integrative Approach to Prevention, Treatment, and Healing

7/17/2017
More
Host: Kathy King, RDN Guest: Lise Alschuler, ND Host Kathy King sits down with Dr. Lise Alschuler, naturopathic doctor, cancer survivor, and author of The Definitive Guide to Cancer: An Integrative Approach to Prevention, Treatment, and Healing. Dr. Alschuler is co-founder of iTHRIVEplan.com, a web application providing personalized wellness plans tailored to cancer survivors. They talk about how integrative medicine specialists approach cancer: its causes, prevention strategies, and ways...

Duration:00:20:29

Linking p53 Variation to Breast Cancer Risk in African American Women

6/19/2017
More
Host: Brian P. McDonough, MD, FAAFP It's widely known that genetics, family history, race, and other factors all play important roles in cancer risk. But what kinds of roles do they play, specifically, and how can we leverage these understandings into better primary care? Dr. Brian McDonough is joined by Dr. Maureen Murphy, research scientist at the Wistar Institute at the University of Pennsylvania. Dr. Murphy has spent the past twenty years studying how genes affect breast cancer risk in...

Duration:00:15:00

FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval

5/30/2017
More
The D.I.S.C.O. hosts discuss the agency’s first approval of pembrolizumab, a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated. Released May 30, 2017.

Duration:00:05:59

FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma

5/22/2017
More
FDA medical oncologists discuss the agency’s March 23, 2017 approval of avelumab for the treatment of patients 12 years and older with metastatic Merkel cell carcinoma. Released May 22, 2017

Duration:00:06:28

The Financial Burden of Cancer: Report from the American Cancer Society

5/22/2017
More
Host: Brian P. McDonough, MD, FAAFP Host Dr. Brian McDonough chats with Jennifer Singleterry, Senior Analyst of Policy and Legislative Support for the American Cancer Society's Cancer Action Network, about the organization's new report revealing monetary burdens for cancer patients.

Duration:00:12:30

FDA D.I.S.C.O.: Niraparib in Ovarian Cancer

5/18/2017
More
FDA medical oncologists discuss the agency’s March 2017 approval of niraparib for the maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy. Released May 18, 2017

Duration:00:05:59

FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer

5/17/2017
More
FDA medical oncologists discuss the agency’s accelerated approval of rucaparib for treatment of patients with deleterious BRCA mutation-associated advanced ovarian cancer who have been treated with two or more chemotherapies. Released May 17, 2017

Duration:00:04:59

Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer

4/17/2017
More
Host: Matt Birnholz, MD Several new screening tests have been developed to help doctors find colorectal cancer early when it's most treatable and can reduce the burden of this disease and the death toll nationwide. Host Dr. Matt Birnholz chats with Dr. John Kisiel, gastroenterologist and Assistant Professor of Medicine at Mayo Clinic College of Medicine, about new screening guidelines for detecting colorectal cancer.

Duration:00:14:30